286 related articles for article (PubMed ID: 17548520)
21. Constitutive association of TGF-beta-activated kinase 1 with the IkappaB kinase complex in the nucleus and cytoplasm of human neutrophils and its impact on downstream processes.
Ear T; Fortin CF; Simard FA; McDonald PP
J Immunol; 2010 Apr; 184(7):3897-906. PubMed ID: 20200282
[TBL] [Abstract][Full Text] [Related]
22. Phosphoinositide-dependent kinase-1 inhibits TRAF6 ubiquitination by interrupting the formation of TAK1-TAB2 complex in TLR4 signaling.
Moon G; Kim J; Min Y; Wi SM; Shim JH; Chun E; Lee KY
Cell Signal; 2015 Dec; 27(12):2524-33. PubMed ID: 26432169
[TBL] [Abstract][Full Text] [Related]
23. Heat shock protein 90 (Hsp90) regulates the stability of transforming growth factor beta-activated kinase 1 (TAK1) in interleukin-1beta-induced cell signaling.
Shi L; Zhang Z; Fang S; Xu J; Liu J; Shen J; Fang F; Luo L; Yin Z
Mol Immunol; 2009 Feb; 46(4):541-50. PubMed ID: 18950863
[TBL] [Abstract][Full Text] [Related]
24. Regulation of IkappaB kinase-related kinases and antiviral responses by tumor suppressor CYLD.
Zhang M; Wu X; Lee AJ; Jin W; Chang M; Wright A; Imaizumi T; Sun SC
J Biol Chem; 2008 Jul; 283(27):18621-6. PubMed ID: 18467330
[TBL] [Abstract][Full Text] [Related]
25. Regulation of the JNK pathway by TGF-beta activated kinase 1 in rheumatoid arthritis synoviocytes.
Hammaker DR; Boyle DL; Inoue T; Firestein GS
Arthritis Res Ther; 2007; 9(3):R57. PubMed ID: 17559674
[TBL] [Abstract][Full Text] [Related]
26. CYLD controls c-MYC expression through the JNK-dependent signaling pathway in hepatocellular carcinoma.
Pannem RR; Dorn C; Ahlqvist K; Bosserhoff AK; Hellerbrand C; Massoumi R
Carcinogenesis; 2014 Feb; 35(2):461-8. PubMed ID: 24104553
[TBL] [Abstract][Full Text] [Related]
27. Role of the stress kinase pathway in signaling via the T cell costimulatory receptor 4-1BB.
Cannons JL; Hoeflich KP; Woodgett JR; Watts TH
J Immunol; 1999 Sep; 163(6):2990-8. PubMed ID: 10477561
[TBL] [Abstract][Full Text] [Related]
28. The deubiquitinase CYLD controls protective immunity against helminth infection by regulation of Treg cell plasticity.
Lee JH; Zou L; Yang R; Han J; Wan Q; Zhang X; El Baghdady S; Roman A; Elly C; Jin HS; Park Y; Croft M; Liu YC
J Allergy Clin Immunol; 2021 Jul; 148(1):209-224.e9. PubMed ID: 33309741
[TBL] [Abstract][Full Text] [Related]
29. Impaired regulation of NF-kappaB and increased susceptibility to colitis-associated tumorigenesis in CYLD-deficient mice.
Zhang J; Stirling B; Temmerman ST; Ma CA; Fuss IJ; Derry JM; Jain A
J Clin Invest; 2006 Nov; 116(11):3042-9. PubMed ID: 17053834
[TBL] [Abstract][Full Text] [Related]
30. The tumor suppressor CYLD controls the function of murine regulatory T cells.
Reissig S; Hövelmeyer N; Weigmann B; Nikolaev A; Kalt B; Wunderlich TF; Hahn M; Neurath MF; Waisman A
J Immunol; 2012 Nov; 189(10):4770-6. PubMed ID: 23066153
[TBL] [Abstract][Full Text] [Related]
31. CTLA-4 (CD152) inhibits T cell function by activating the ubiquitin ligase Itch.
Hoff H; Kolar P; Ambach A; Radbruch A; Brunner-Weinzierl MC
Mol Immunol; 2010 Jun; 47(10):1875-81. PubMed ID: 20417562
[TBL] [Abstract][Full Text] [Related]
32. CYLD negatively regulates transforming growth factor-β-signalling via deubiquitinating Akt.
Lim JH; Jono H; Komatsu K; Woo CH; Lee J; Miyata M; Matsuno T; Xu X; Huang Y; Zhang W; Park SH; Kim YI; Choi YD; Shen H; Heo KS; Xu H; Bourne P; Koga T; Xu H; Yan C; Wang B; Chen LF; Feng XH; Li JD
Nat Commun; 2012 Apr; 3():771. PubMed ID: 22491319
[TBL] [Abstract][Full Text] [Related]
33. TAK1-mediated transcriptional activation of CD28-responsive element and AP-1-binding site within the IL-2 promoter in Jurkat T cells.
Sakurai H; Singhirunnusorn P; Shimotabira E; Chino A; Suzuki S; Koizumi K; Saiki I
FEBS Lett; 2005 Dec; 579(29):6641-6. PubMed ID: 16293250
[TBL] [Abstract][Full Text] [Related]
34. Down-regulation of CYLD as a trigger for NF-κB activation and a mechanism of apoptotic resistance in hepatocellular carcinoma cells.
Urbanik T; Köhler BC; Boger RJ; Wörns MA; Heeger S; Otto G; Hövelmeyer N; Galle PR; Schuchmann M; Waisman A; Schulze-Bergkamen H
Int J Oncol; 2011 Jan; 38(1):121-31. PubMed ID: 21109933
[TBL] [Abstract][Full Text] [Related]
35. Protective dendritic cell responses against listeriosis induced by the short form of the deubiquitinating enzyme CYLD are inhibited by full-length CYLD.
Wurm R; Just S; Wang X; Wex K; Schmid U; Blanchard N; Waisman A; Schild HJ; Deckert M; Naumann M; Schlüter D; Nishanth G
Eur J Immunol; 2015 May; 45(5):1366-76. PubMed ID: 25675948
[TBL] [Abstract][Full Text] [Related]
36. Mutated cylindromatosis gene affects the functional state of dendritic cells.
Bros M; Dexheimer N; Besche V; Masri J; Trojandt S; Hövelmeyer N; Reissig S; Massoumi R; Grabbe S; Waisman A; Reske-Kunz AB
Eur J Immunol; 2010 Oct; 40(10):2848-57. PubMed ID: 20836156
[TBL] [Abstract][Full Text] [Related]
37. PP6 controls T cell development and homeostasis by negatively regulating distal TCR signaling.
Ye J; Shi H; Shen Y; Peng C; Liu Y; Li C; Deng K; Geng J; Xu T; Zhuang Y; Zheng B; Tao W
J Immunol; 2015 Feb; 194(4):1654-64. PubMed ID: 25609840
[TBL] [Abstract][Full Text] [Related]
38. Toll-like receptor 4 signalling is specifically TGF-beta-activated kinase 1 independent in synovial fibroblasts.
Geurts J; van den Brand BT; Wolf A; Abdollahi-Roodsaz S; Arntz OJ; Kracht M; van den Berg WB; van de Loo FA
Rheumatology (Oxford); 2011 Jul; 50(7):1216-25. PubMed ID: 21335610
[TBL] [Abstract][Full Text] [Related]
39. Semaphorin 7A is a negative regulator of T cell responses.
Czopik AK; Bynoe MS; Palm N; Raine CS; Medzhitov R
Immunity; 2006 May; 24(5):591-600. PubMed ID: 16713976
[TBL] [Abstract][Full Text] [Related]
40. TAK1 and IKK2, novel mediators of SCF-induced signaling and potential targets for c-Kit-driven diseases.
Drube S; Weber F; Göpfert C; Loschinski R; Rothe M; Boelke F; Diamanti MA; Löhn T; Ruth J; Schütz D; Häfner N; Greten FR; Stumm R; Hartmann K; Krämer OH; Dudeck A; Kamradt T
Oncotarget; 2015 Oct; 6(30):28833-50. PubMed ID: 26353931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
